AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05702593 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Static stretching
Description: The participant was positioned supine for static stretching to be applied to the hamstring muscles. The physiotherapist flexed the participant's hip to the point where resistance to the movement was first observed, with the knee extended.At this point, after waiting for 40 seconds, it was returned to the previous position. This application was made on both sides \[Bretischwerdt\]. The technique was repeated three times, with a 15-second rest interval between each repetition.
Study NCT05702593 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Myofascial Release
Description: For hamstring muscles, the participants were asked to assume a long sitting position on a firm, flat surface with their arms behind their backs and their body weight on their palms. A foam roller was placed under the hamstring muscles and slowly moved the tuberositas ischii popliteus back and forth with pressure for 4 minutes.
Study NCT05702593 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Myofascial Release
Description: For hamstring muscles, the participants were asked to assume a long sitting position on a firm, flat surface with their arms behind their backs and their body weight on their palms. A foam roller was placed under the hamstring muscles and slowly moved the tuberositas ischii popliteus back and forth with pressure for 4 minutes.
Study NCT06453291 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Neuromodulation via Dorsal Root Ganglion (DRG):
Description: Objective: To modulate excitatory pathways and reduce pain through targeted stimulation.~Procedure:~Placement of electrodes near the DRG. Application of pulsed radiofrequency (RF) at 42°C for 3-20 minutes.~Frequency:~Initial treatment: Once a week for the first month. Maintenance: Monthly sessions if needed. Duration: Each session lasts approximately 30-45 minutes. Monitoring: Pain levels and functional improvement will be assessed before and after each session.
Study NCT06453291 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Platelet-Rich-Plasma Therapy
Description: Objective: To promote healing and reduce inflammation through the application of concentrated platelets.~Procedure:~Blood draw from the patient. Centrifugation to separate platelets. Injection of PRP into the affected area of the lower back.~Frequency:~Initial treatment: Once a week for the first three weeks. Follow-up: Additional injections may be given based on patient response and clinical judgment.~Duration: Each session lasts approximately 30-45 minutes. Monitoring: Pain levels, inflammation markers, and functional improvement will be assessed before and after each injection.
Study NCT06426849 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Liuzijue Exercise
Description: LiuzijueExercise includes inhalation and exhalation through various mouth patterns to manage and control the rise and fall of the breath in the body. It is performed by delivering 6 distinct sounds, (xū,hē, hū sī, chuī, and xī) through termination along with comparing body activities.~The following are 6-8 vital parts of body movements:~1. Swaying and twisting~2. Hip rotations~3. Arm movements~4. Knee bends~5. Foot pivots~6. Spine elongation~7. Hand gestures~8. Breath synchronization Frequency: 1 session per day for a week Intensity:In first week 1 set of Luizijue exercise will be performed then progressively increase to 4 sets till 6th week .~Total Time for Session; 40 minutes Warm-up Time: 10 minutes with pursed lip breathing Cool Down Time: 10 minutes with upper body gentle stretching. Exercise Duration: 20 minutes for Luizijue Exercise.
Study NCT06426849 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tai Chi Chuan Exercise
Description: Tai Chi Chuan Exercise combines deep diaphragmatic breathing and relaxation with many fundamental postures.~Names of the 10 Movements in Sequence~1. Commencing Form~2. Repulsing the Monkey~3. Brush Knee~4. Parting the Horse's Mane~5. Cloud Hands~6. Golden Cockerel Standing on the Left, then the Right~7. Kick Out Right, Kick Out Left~8. Grasping the Bird's Tail~9. Cross Hands or Embrace the Tiger~10. Closing Form Frequency: 3 sessions / week Intensity: Initially each posture will be performed 3 times then progressively leads to 6 or 10 reps according to patient tolorance.~Total Time for Session; 40 minutes Warm-up Time: 10 minutes with pursed lip breathing Cool Down Time: 10 minutes with upper body gentle stretching. Exercise Duration: 20 minutes for Tai Chi Chuan Exercise.
Study NCT05348486 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Dose escalation
Description: Dose escalation 75,9 - 79,2 Gy in 33 fractions for GTV hypoxic or any hypoxic LN > 2cm
Study NCT05755568 — intervention group
Intervention type: OTHER
Intervention: No Intervention
Description: As this is an observational study, no intervention will be administered.
Study NCT04941326 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Costal mobilization
Description: In the supine position, the individual will place both hands around the 10-12th ribs and alternately apply an oblique push from the right and left sides to the opposite side. The exercise will be taught to the patient as training, and he will be asked to apply it 2 times a day with 20 repetitions for 4 weeks.
Study NCT04941326 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Breathing exercises
Description: It is done to increase the diaphragm activity of the individual and to suppress chest breathing. While lying in the supine position, the legs are placed in a hooked position, with one hand on the abdomen and the other on the chest, and the deep breath that is taken from the nose in 2 seconds is asked to exhale through the mouth in 4 seconds, while revealing as little movement in the chest as possible, the main movement is requested to be around the abdomen. The application will be given to the patient as a home program and he will be asked to do it 2 times a day with 5 repetitions for 4 weeks.
Study NCT04941326 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Breathing exercises
Description: It is done to increase the diaphragm activity of the individual and to suppress chest breathing. While lying in the supine position, the legs are placed in a hooked position, with one hand on the abdomen and the other on the chest, and the deep breath that is taken from the nose in 2 seconds is asked to exhale through the mouth in 4 seconds, while revealing as little movement in the chest as possible, the main movement is requested to be around the abdomen. The application will be given to the patient as a home program and he will be asked to do it 2 times a day with 5 repetitions for 4 weeks.
Study NCT04941326 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Spinal mobilization
Description: T12 vertebrae will be found by following the 12th rib in the prone position of the individual and spinous of L1 and L2 vertebrae will be determined with this reference. Then, small amplitude rotational movements in the vertebrae will be revealed by pushing in the anterior direction over the transverse processes. This application will be applied once a week for an average of 10 minutes for 4 weeks.
Study NCT05449054 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Anterior colporrhaphy
Description: All patients will be operated by the vaginal route. They are prepared under strict aseptic conditions in the dorsal lithotomy position. The bladder is emptied preoperatively with a thin disposable catheter and antibiotic prophylaxis (cefazolin) is administered before incision. A vasoconstricting solution (combination of vasopression and NaCl) is administered and a vertical anterior vaginal incision is made from the apex to two centimeters short of the external urethral meatus using an electric cautery or a scalpel. The vaginal epithelium is grasped on both sides and the fibromuscular layer of the anterior vaginal wall is sharply dissected laterally to the inferior pubic ramus. The bladder is completely dissected from the apex and up to 4 to 6 cm from the pubic ramus. The anterior colporrhaphy is defined as a native tissue repair and rows of absorbable sutures (2/0 vicryl) are used.
Study NCT04941326 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham mobilization
Description: Sham pressures will be applied to the lumbar region of the patient, away from the vertebrae. This application will be applied once a week for an average of 10 minutes for 4 weeks.
Study NCT04779879 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Sotrovimab (Gen1)
Description: Participants will be randomized to receive an IV infusion of Sotrovimab Gen 1 material
Study NCT04779879 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Sotrovimab (Gen2)
Description: Participants will be randomized to receive Sotrovimab Gen2 material by IV infusion or by IM injection
Study NCT04779879 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Sotrovimab (Gen2)
Description: Participants will be randomized to receive Sotrovimab Gen2 material by IV infusion
Study NCT05419076 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Radiosurgery
Description: All participants will undergo MSK standard SRS. A CT simulation will be performed per institutional standards, typically with contrast unless a contraindication exists. A contrast-enhanced MRI with 1mm slices will be fused to the CT simulation scan for the purposes of SRS planning. The SRS GTV will be considered the visible tumor on MRI and CT contrast enhanced studies. An expansion of 1-2mm will be used to create the PTV. Radiation dose may be between 16Gy and 30Gy in 1 to 5 fractions, per the discretion of the treating radiation oncologist. Participants with multiple lesions may receive different doses to each lesion per the discretion of the treating radiation oncologist. Concurrent treatment to other body sites is permitted.
Study NCT05419076 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid collection
Description: All participants will undergo lumbar puncture for CSF collection at study enrollment.. Lumbar punctures will be performed by clinical staff in neurology or neuroradiology, per the discretion of the treating radiation oncologist, as dictated by scheduling limitations and expected clinical difficulty in obtaining a sample (e.g. requiring fluoroscopic guidance), with input from the PI, neurology, and/or neuroradiology as necessary. Participants will be encouraged to undergo repeat lumbar puncture for CSF collection at 3 months (+/- 4 weeks), and at the time of CNS disease progression, though these latter timepoints are not required. CSF cytology will be evaluated.
Study NCT04703114 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Blood count
Description: Blood count at each visit
Study NCT04703114 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Blood collection
Description: Blood collection to understanding of the immunological profile at each visit
Study NCT04703114 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Nasopharyngeal swab
Description: Research of SARS-CoV-2 infection in nasopharyngeal swab by RT-PCR at day 8 and day 15
Study NCT06583811 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Remifentanil
Description: to compare remifentanil and remimazolam to limit patient movement during long-eye surgeries under local anesthesia.
Study NCT04703114 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Saliva samples
Description: Research of SARS-CoV-2 infection in saliva samples at each visit (excepted inclusion)
Study NCT04703114 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Faeces samples
Description: Research of SARS-CoV-2 infection in faeces samples at day 3, day 15 and day 90
Study NCT04703114 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: Genetic blood collection
Description: Collection to further research at each visit
Study NCT04703114 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Data collection
Description: Demographics, symptoms, biological constants
Study NCT05455502 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VX-548
Description: Tablet for oral administration.
Study NCT06200883 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral vial
Description: In the Placebo group the participants take vehicle (1 vial per os every 24 hours) for 4 weeks
Study NCT06200883 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Choline Bitartrate
Description: In the CEREBRAIN group the participants take CEREBRAIN (1 vial per os of 1.2 g every 24 hours) for 4 weeks
Study NCT05994079 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: High intensity focused ultrasound
Description: Parameters:~Transducer frequency 7-2-mhz 1.5-9.0-mm focal depth. The pulse duration for each individual exposure ranged from 25 to 40 milliseconds.~Energy per ultrasound pulse ranged from 1.0 to 1.5 J
Study NCT05994079 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: topical firming creams
Description: medical topical firming creams
Study NCT05884944 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham- Light touch, not reaching restrictive barrier
Description: Sham- Light touch, not reaching restrictive barrier For the control group, the subjects hip, knee, and ankle joints will be moved bilaterally 3 times into each plane to mimic the OMM muscle energy treatment. The joint will be moved in each plane of motion without reaching the joint barrier. The hip joint will be moved into adduction, extension, and flexion, the knee joint will be moved into extension and flexion, and the ankle will be moved into plantarflexion and dorsiflexion 3 times in each direction without reaching the barrier passively.
Study NCT05796271 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: R-Chop and Roflumilast
Description: All subjects will receive R-CHOP therapy at standard doses according to the standard preparation and infusion procedures of each investigational site, which is to be repeated every 21 days (+/- 3 days) for a total of 6 cycles. All subjects will receive a fixed oral dose of one 500 microgram (μg) tablet of roflumilast per day with or without food for all 21 days of each cycle, which will amount to a total of 126 doses. Subjects will be asked to keep a drug diary to record the days and times when Roflumilast is taken. The first dose will be given on the day of the first R-CHOP treatment.
Study NCT06562881 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scheduling Navigation
Description: Participants will be connected to a scheduler to schedule a surgical consultation visit at time of recruitment. Participation does not guarantee or require surgery.
Study NCT06562881 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Without Scheduling Navigation
Description: Patients will work with clinic staff in the usual fashion for their treatment for primary hyperparathyroidism. They will not be connected directly to a scheduler to help schedule a surgical consultation visit at time of recruitment. With our crossover design, if patients have not yet received surgical consultation after 3 months, they will be called and connected with a scheduler at that time. Participation does not guarantee or require surgery.
Study NCT05902572 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: Observational data collection only.
Study NCT05653817 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carrilizumab
Description: Carrilizumab 200mg Q3W d1
Study NCT05653817 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Albumin-bound paclitaxel
Description: Albumin-bound paclitaxel 125 mg/m2 d1,8
Study NCT05653817 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apatinib
Description: Apatinib mesylate tablets for treatment: 250mg
Study NCT05663957 — intervention group
Intervention type: DRUG
Intervention: Evusheld
Description: EVUSHELD users
Study NCT06416410 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JAB-21822
Description: JAB-21822 administered orally as a tablet
Study NCT06416410 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tislelizumab
Description: Tislelizumab administered as an intravenous (IV) infusion
Study NCT06416410 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: JAB-3312
Description: JAB-3312 administered orally as a tablet or capsule
Study NCT06416410 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pemetrexed
Description: Pemetrexed administered as an intravenous (IV) infusion
Study NCT06416410 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin administered as an intravenous (IV) infusion
Study NCT06010264 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesiotape
Description: In the kinesiotaping group, kinesiotape was applied from the first postoperative day in addition to conservative treatment.~Kinesiobant application was performed regularly until the 6th week by a researcher with a certificate in kinesiobanting in accordance with the lymphatic correction and pain inhibition techniques described by Kenzo Kase.~Conservative Treatment Program. 1-10 days: Patient education Pendulum exercises Active hand and wrist exercises Cold Application 1-6 Weeks: Pendulum exercises are continued Active hand and wrist exercises are continued Cold application is continued Passive arm elevation with opposite hand support in supine position Elbow flexion/extension exercise at the limit of pain
Study NCT06010264 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Shamtape
Description: In the sham taping group, sham tape was applied from the first postoperative day in addition to conservative treatment. Medical flasters were used as sham tape. Sham tapes were applied by cutting in the same fan shape as in kinesioband.~Conservative Treatment Program. 1-10 days: Patient education Pendulum exercises Active hand and wrist exercises Cold Application 1-6 Weeks: Pendulum exercises are continued Active hand and wrist exercises are continued Cold application is continued Passive arm elevation with opposite hand support in supine position Elbow flexion/extension exercise at the limit of pain
Study NCT06010264 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard Physiotherapy Program
Description: Conservative Treatment Program. 1-10 days: Patient education Pendulum exercises Active hand and wrist exercises Cold Application 1-6 Weeks: Pendulum exercises are continued Active hand and wrist exercises are continued Cold application is continued Passive arm elevation with opposite hand support in supine position Elbow flexion/extension exercise at the limit of pain
Study NCT05834348 — intervention group
Intervention type: DRUG
Intervention: lorlatinib
Description: As provided in real world practice
Study NCT05834348 — intervention group
Intervention type: DRUG
Intervention: crizotinib
Description: As provided in real world practice
Study NCT05834348 — intervention group
Intervention type: DRUG
Intervention: brigatinib
Description: As provided in real world practice
Study NCT05834348 — intervention group
Intervention type: DRUG
Intervention: ceritinib
Description: As provided in real world practice
Study NCT05834348 — intervention group
Intervention type: DRUG
Intervention: alectinib
Description: As provided in real world practice
Study NCT05834348 — intervention group
Intervention type: DRUG
Intervention: atezolizumab
Description: As provided in real world practice
Study NCT05834348 — intervention group
Intervention type: DRUG
Intervention: bevacizumab
Description: As provided in real world practice
Study NCT05834348 — intervention group
Intervention type: DRUG
Intervention: paclitaxel
Description: As provided in real world practice
Study NCT05834348 — intervention group
Intervention type: DRUG
Intervention: carboplatin
Description: As provided in real world practice
Study NCT05834348 — intervention group
Intervention type: DRUG
Intervention: docetaxel
Description: As provided in real world practice
Study NCT05834348 — intervention group
Intervention type: DRUG
Intervention: erlotinib
Description: As provided in real world practice
Study NCT05834348 — intervention group
Intervention type: DRUG
Intervention: gefitinib
Description: As provided in real world practice
Study NCT05834348 — intervention group
Intervention type: DRUG
Intervention: afatinib
Description: As provided in real world practice
Study NCT05834348 — intervention group
Intervention type: DRUG
Intervention: dacomitinib
Description: As provided in real world practice
Study NCT05834348 — intervention group
Intervention type: DRUG
Intervention: osimertinib
Description: As provided in real world practice
Study NCT06299774 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Emergency care at home
Description: A mobile integrated health paramedic under the direction of a remote emergency care physician will arrive at the patient's home and deliver emergency care.
Study NCT06299774 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Emergency care at a brick-and-mortar emergency department
Description: Standard emergency care delivered in a brick-and-mortar emergency department.
Study NCT05834348 — intervention group
Intervention type: DRUG
Intervention: pembrolizumab
Description: As provided in real world practice
Study NCT05834348 — intervention group
Intervention type: DRUG
Intervention: nivolumab
Description: As provided in real world practice
Study NCT05834348 — intervention group
Intervention type: DRUG
Intervention: entrectinib
Description: As provided in real world practice
Study NCT06366230 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Urea in the dialysate
Description: Adding urea to the dialysis fluid. Ure-Na 15 grams would be used. It would be added to the acid component of the dialysis fluid. The amount added would depend on the serum BUN concentration and is determined by a simple calculation. It would be available in powder form. Urea would be added just to the first 1-3 dialysis treatments as needed.
Study NCT06051006 — intervention group
Intervention type: OTHER
Intervention: ESR and ECAP measurements
Description: Measurement of electrically evoked stapedial reflexes (ESRT) by stimulation via the cochlear implant. Measurement of the Electric compound action potentials (ECAPs) on the electrodes where the ESRT were performed.~The measurements and tests will be performed during a routine visit to the Necker hospital for the adjustment of the cochlear implant (visit 1).